Abstract
African mushrooms remain underexploited for biopharmaceuticals for application in modern medicine. Yet, amidst the rich use of mushrooms in African folk medicine and the high rates of endemic diseases plaguing the continent, the need for a critical exposé of African mushrooms as biopharmaceuticals and phytoceuticals is imperative and hereby presented. Generally, mushrooms are rich sources of many bioactive compounds that are important to our health servicing. They are a good source of proteins that are important to all body functions. Mushroom proteins are of very high quality and are rich in the most important essential amino acids. They are an excellent source of most B vitamins, and the primary natural source of ergosterol or provitamin D, and also essential minerals such as zinc and selenium. Malnutrition and stunting are largely a health problem in rural Africa. Mushrooms are abundant in nutrients that can potentially stamp out nutritional deficiencies in African children. While many people who eat balanced diets receive all the needed minerals, some get more sodium than they need. Mushrooms have the benefits of low sodium, low cholesterol, and higher potassium and iron than most foods. Chitin which is present in many African mushrooms such as Pleurotus tuber-regium, Termitomyces spp., Pleurotus spp., and Agaricus spp. is the primary structural material in mushrooms and has been shown to be of immense value as dietary fiber. It can also be hydrolyzed to glucosamine, which is widely accepted by physicians for treatment of chronic diseases of aging people such as autoimmune disorders and arthritis. Also it is used as a valuable food supplement for the prevention and alleviation of osteoarthritis. β-Glucans widely identified in a number of African mushrooms such as Ganoderma spp., African truffles, and Agaricus spp. are valuable immune regulatory substances that can treat and manage different cancers, diabetes, and other cardiovascular disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DNA:
-
Deoxyribonucleic acid
- FDA:
-
Food and Drug Administration
- HDL:
-
High-density lipoprotein
- LDL:
-
Low-density lipoprotein
- NCDs:
-
Noncommunicable Diseases
References
Albershiem P (1976) The primary cell wall. In: Bonner J, Varner JE (eds) Plant biochemistry, 3rd edn. Academic, New York, pp 226–274
Aoyagi Y, Kasuga A, Sasaki H, Matuzawa M, Tsutagawa Y, Kawai H (1993) Chemical composition of shitake mushroom cultivated on logs and sawdust substrate beds and their relations to composition of the substrate. Nippon Shokuhin Kogyo Gakkaishi 40:771–775
Austin PR, Brine CJ, Castle JE, Zikakis JP (1981) Chitin: new facets of research. Science 212:749–753
Bano Z, Bhagya S, Srinivasan KS (1981) Essential amino acid composition and proximate analysis of the mushroom Pleurotus eous and P. florida. Mushroom Newslett Trop 1(3):6–10
Braham R, Dawson B, Goodman C (2003) The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med 37:45–49
Brzezinski R, LeHoux JG, Kelly A (2004) Clinical studies on the innocuousness of chitosan and its short-chain derivative generated by enzymatic hydrolysis. Asia Pacific J Clin Nutr 13:S96
Chang ST (1972) The Chinese mushroom. The Chinese University of Hong Kong, Hong Kong, p 113
Chang ST (1993) Mushroom biology: the impact on mushroom production and mushroom products. In: Chang et al (eds) Mushroom biology and mushroom products. The Chinese University Press, Hong Kong, pp 3–20
Chang ST (1999) Global impact of edible and medicinal mushrooms on human welfare in the 21st Century: non-green revolution. Int J Med Mushrooms 1:1–7. https://doi.org/10.1615/IntJMedMushrooms.v1.i1.10
Cheung PC (1998) Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. J Nutr 128:1512–1516
Chioza A, Ohga S (2014) Cultivated mushrooms in Malawi: a look at the present situation. Adv Microbiol 4(1):6–1174
Cho YW, Cho YN, Chung SH, Yoo G, Ko SW (1999) Water-soluble chitin as a wound healing accelerator. Biomaterials 20:2139–2145
FDA (1998) http://www.fda.gov/cder/foi/label/1998/209261bl.pdf
FDA (2000) http://www.fda.gov/cder/foi/label/2000/211761bl.pdf
Fenton JI, Chlebek-Brown KA, Peters TL, Carson JP, Orth MW (2000) Glucosamine HCL reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 8:258–265
Foster AB, Webber JM (1960) Chitin. Adv Carbohydrate Chem 15:371–393
Furda I (1983) Aminopolysaccharides-their potential as dietary fiber. In: Furda I (ed) Unconventional sources of dietary fibers. American Chemical Society, Washington, DC, pp 105–122
Gallaher DD, Gallaher CM, Mahrt GJ, Carr TP, Hollingshead CH, Heslink R Jr, Wise J (2002) A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am College Nutr 21:428–433
Gordon DT, Williford CB (1983) Chitin and chitosan: influence on absorption in rats. In: Furda I (ed) Unconventional sources of dietary fibers. American Chemical Society, Washingon, DC, pp 155–184
Katz DL (2001) A scientific review of the health benefit of oats. The Quaker Oats Company. http://www.quakeroatmeal.com/healthpros/IHP/HealthBenefitsofOats.pdf
Kogure T (1975) On the specificity of mushroom Pleurotus ostreatus and Pleurotus spodoleucus extracts. Vox Sanguinis 29:221–227
Kurtzman RH Jr (1975) Mushrooms as a source of food proteins. In: Friedman M (ed) Protein nutritional quality of foods and feeds, part 2. Marcel Dekker, New York, pp 305–318
Kurtzman RH Jr (1991) Dolomite upsets the carbon dioxide balance. Mushroom Sci 13:747–751
Kurtzman RH Jr (1993) Analysis, digestibility and the nutritional value of mushrooms. In: Chang et al (eds) Mushroom biology and mushroom products. Chinese University Press, Shatin
Kurtzman RH Jr (1997) Nutrition from mushrooms, understanding and reconciling available data. Mycoscience 40:247–253
Mattila P, Lampi AM, Ronkainen R, Toivo J, Piironen V (2002) Sterols and vitamin D2 contents in some wild and cultivated mushrooms. Food Chem 76:293–298. https://doi.org/10.1016/S0308-8146(01)00275-8
McCarty MF (1998) Enhanced synovial production of hyaluronic acid may explain rapid clinical responses to high-dose glucosamine in osteoarthritis. Med Hypotheses 50(6):507–510
Mello DM, Brian MS, Nielson D et al (2004) Comparison of inhibitory effects of glucosamine and mannosamine on bovine articular cartilage degradation in vitro. Am J Vet Res 65:1440–1445. https://doi.org/10.2460/ajvr.2004.65.1440
Mpeketula PMG (2008) Indigenous mushroom species cultivation, processing and utilization for food security and conservation. National Research Council of Malawi, Conference Proceedings, Malawi, pp 95–105
Noller CR (1951) Chemistry of organic compounds. WB Saunders, Philadelphia, p 885
Okhuoya JA, Akpaja EO, Osemwegie OO, Oghenekaro AO, Ihayaere CA (2010) Nigerian mushrooms: underutilized non-wood forest resources. Environ Manag 14(1):43–54
Ormrod DJ, Holmes CC, Miller TE (1998) Dietary chitosan inhibits hypercholesterolemia and atherogenesis in apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138(2):329–334
Orth MW, Peters TL, Hawkins JN (2002) Inhibition of articular cartilage degradation by glucosamine-HCL and chondroitin sulfate. Equine Vet J Suppl 34:224–229
Ortiz R, Sanchez R, Piez A, Montaio LF, Zenteno E (1992) Induction of intestinal malabsorption syndrome in rats fed with Agaricus bisporus mushroom lectin. J Agric Food Chem 40:1375–1378
Outila T, Mattila PH, Piironen VI, Lamberg-Allardt CJ (1999) Bioavailability of vitamin D from wild edible mushrooms (Cantharellus tubaeformis) as measured with a human bioassay. Am J Clin Nutr 69:95–98
Presant P, Kornfeld S (1972) Characterization of the cell surface receprot for the Agaricus bisporus Hemagglutinin. J Biol Chem 247(21):6937–6945
Razdan A, Pettersson R (1994) Effect of chitin and chitosan on nutrient digestibility and plasma lipid concentrations in broiler chickens. Br J Nutr 72:277–288
Robson G (1999) Hyphal cell biology. In: Oliver RP, Schweizer M (eds) Molecular fungal biology. Cambridge University Press, Cambridge, pp p164–p184
Sanchez JE, Huerta G, Montiel E (eds) (2002) Mushroom biology and mushroom products, Proceedings of the 1V international conference. University of Morelos, Cuernavaca, Mexico, p 468
Su CH, Lin BW, Yu SY, Liu SW (2004) Use of Ganoderma tsugae for the treatment of human chronic skin ulcers. Mushroom Sci 16:659–662
Wakita S (1976) Thiamine-destruction by mushrooms. Sci Rep Yokohama Natl Univ Sect 2 23:39–70
Windholtz M (1983) The Merck Index, 10th ed. Merck & Co., Rahway, pp 1463–1481
Wittliff JL, Airth RL (1970) Thiaminase I. (Thiamine: base 2-methyl-4aminopyrimidine-5-methenyl transferase, EC 2.5.1.2). Methods Enzymol 18(A):234–238. https://doi.org/10.1016/0076-6879(71)18310-3
Yongabi KA (2007) Ethnomycology of grassland fields and tropical rainforest of Cameroon. Poster presentation at the ‘First World Conference on Conservation and Sustainable Use of Wild Fungi’, organized by the Regional Government of Andalucia, Spain, 10–16 December, pp 298–299
Yongabi A (2014) Current developments in mushroom biotechnology in sub Saharan Africa. WSMBMP Bull 11:4–13
Yongabi K, Agho M, Martinez-Carrera D (2004) Ethnomycological studies on wild mushrooms in Cameroon, Central Africa. Micologia Aplicada Int 16(2):34–36
Yongabi A, Laura D, Keto M, Suki KKM, Alex D, Francisca NN (2015) Can we exploit and adapt indigenous knowledge and ethnobotanicals for a healthy living in the face of emerging diseases like Ebola in Africa. Am J Clin Exp Med 3:24–28. https://doi.org/10.11648/jcem.s.2015030101.15
Yusof NL, Wee A, Lim LY, Khor E (2003) Flexible chitin films as potential wound-dressing materials: wound model studies. J Biomed Mater: Res A 66(2):224–232
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yongabi, K.A. (2019). African Medicinal Mushrooms: Source of Biopharmaceuticals for the Treatment of Noncommunicable Diseases – A Review. In: Agrawal, D., Dhanasekaran, M. (eds) Medicinal Mushrooms. Springer, Singapore. https://doi.org/10.1007/978-981-13-6382-5_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-6382-5_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6381-8
Online ISBN: 978-981-13-6382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)